Marex Group plc chief executive Ian Lowitt filed a Form 144 notice on November 17, 2026, disclosing a proposed sale of 32,465 shares of common stock through J.P. Morgan Securities LLC on Nasdaq.

Key Highlights

  • Seller and role: Ian Lowitt, CEO of Marex Group plc, is the person for whose account the securities are to be sold.
  • Shares proposed for sale: 32,465 shares of common stock, with an aggregate market value of $2,276,446, according to the filing.
  • Shares outstanding: The filing reports 72,937,470 shares of common stock outstanding.
  • Acquisition details: The shares were acquired on October 10, 2025, via open market purchase, with cash payment on the same date.
  • 10b5-1 plan: The filing states the sales "are made in connection with a selling plan entered into on August 15, 2026 that is intended to comply with Rule 10b5-1."
  • Approximate sale date: November 17, 2026, through broker J.P. Morgan Securities LLC.
  • Prior sales: The filing reports nothing to report under securities sold during the past 3 months.

Marex Group CEO Lowitt Discloses Proposed Common Stock Sale Under Rule 144

According to the Form 144 notice filed with the U.S. Securities and Exchange Commission, Ian Lowitt, the chief executive officer of Marex Group plc (NASDAQ:MRX), has provided notice of a proposed sale of 32,465 shares of the company's common stock. The filing lists an aggregate market value of $2,276,446 for the proposed transaction, with the approximate date of sale given as November 17, 2026. The broker named in the filing is J.P. Morgan Securities LLC, located at 270 Park Avenue, 10th Floor, New York, NY 10017.

The filing discloses that the shares proposed for sale were acquired by Lowitt on October 10, 2025, through an open market purchase, with full cash payment made on the same date. The company's SEC file number is listed as 001-42020, and its registered address is 155 Bishopsgate, London EC2M 3TQ, United Kingdom. As of the filing, 72,937,470 shares of common stock were listed as outstanding.

The filing includes a remark stating that the proposed sales "are made in connection with a selling plan entered into on August 15, 2026 that is intended to comply with Rule 10b5-1" under the Securities Exchange Act. The date of plan adoption is recorded as August 15, 2026. The notice was signed by J.P. Morgan Securities LLC as agent and attorney-in-fact for Ian Lowitt. No securities sold during the prior three months were reported.

What Was Disclosed

Marex Group plc CEO Ian Lowitt filed a Form 144 notice proposing the sale of 32,465 common shares with an aggregate market value of $2,276,446, under a Rule 10b5-1 plan adopted August 15, 2026, with the sale expected on November 17, 2026 via J.P. Morgan Securities LLC.